NEW YORK, Nov. 2, 2007 (PRIME NEWSWIRE) -- CEOs from Argenta Oil & Gas Inc. (TSX-V:AZA), Amira Pharmaceuticals, and Condor Resources Plc (LSE:CNR) tell Wall Street Reporter about their companies' plans for explosive growth. The interviews can be listened to, or downloaded, at www. WallStreetReporter.com.
Amira Pharmaceuticals is quickly adding capabilities in product development, commercialization, and financial analysis, though their core is in research. CEO Robert Baltera, Jr. explains, "It doesn't just end at great science. You need great science, great medicine, great commercialization, detailed understanding of patent protection, and great regulatory understanding."
Highlights of the Interview:
-- Amira's plans for a joint venture for their lead molecule, the
5-lipoxygenase inhibitor.
-- The drug-development team's "proven track record of developing and
bringing drugs to market."
-- Management's meticulous attention to patent protection.
"We are really starting up," says Claudio Larotonda, CEO of another promising startup, Argenta Oil & Gas Inc. (TSX-V:AZA), who was also interviewed. "We are going to be drilling in one month and a half. We are really active in acquisitions," Mr. Larotonda adds. "So, I think we are going to have pretty good news pretty soon. I think the investment community understands this is a new breed of South American independent. It's a South American company run by South Americans."
Highlights of the Interview:
-- Management's goal to reach 40,000 barrels per day in the next 5
years.
-- Argenta's ownership of 294,000 acres, which are distributed in 3
blocks.
-- The company's Loma El Divisadero Project, of which it owns 100%.
Another rapidly growing company, Condor Resources Plc (LSE:CNR) is currently focused on growing through its projects in Central America. "In two to three years, I would expect Condor to have a couple million ounces on its books," CEO Nigel Ferguson BSc MAusIMM tells us. "We're quite aggressive in picking up licenses and looking at them quite hard to make sure they'll give us a return."
Highlights of the Interview:
-- Condor's involvement in joint ventures on 3 of its 6 Nicaraguan
projects.
-- The current trenching program on the company's lead project in El
Salvador, La Calera.
-- The company's 112,000 ounce resource at La Calera, where they are
awaiting permits to drill.
Wall Street Reporter (Est. 1843) is the premier source of investment information on global small-cap public companies in high-growth sectors. Through their magazines, special reports, web site, and conferences, WSR presents unique opportunities for discovering stocks before they appear on the radar of Wall Street and have become "must-attends" and "must-reads" for the "who's who" of the investment community.
These interviews can be heard, or downloaded, now at www.WallStreetReporter.com. Listeners can also subscribe to the free podcast via Apple iTunes.
About Amira Pharmaceuticals
Amira Pharmaceuticals is a startup pharmaceutical company based in San Diego, CA. Already an experienced and proven team of drug developers, the company is currently adding commercialization, financial analysis, and product development capabilities.
About Argenta Oil & Gas Inc.
Argenta Oil & Gas Inc. is an independent Latin American oil and gas company with assets concentrated in Argentina, Columbia, Trinidad, and Tabogo. The company owns 294,000 acres, distributed in 3 blocks. Management is confident that the company will reach its goal of 40,000 barrels per day in the next 5 years.
About Condor Resources Plc
Condor Resources Plc is a UK-based exploration company, focused on silver and gold in Central America. Presently, the company holds 4 major assets in El Salvador and 6 in Nicaragua, 3 of which are under joint ventures. Management expects to have 2 million ounces on the books in the next 2 to 3 years.
Forward-Looking Statements
Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.